Validity, reliability, and responsiveness of daily monitoring visual analog scales in MASK-air®

Data de publicação: Data Ahead of Print:

Autores da FMUP

  • Bernardo Manuel De Sousa Pinto

    Autor

  • Ana Margarida Barbosa Ribeiro Pereira

    Autor

  • João De Almeida Lopes Da Fonseca

    Autor

Participantes de fora da FMUP

  • Eklund, P
  • Pfaar, O
  • Klimek, L
  • Zuberbier, T
  • Czarlewski, W
  • Bédard, A
  • Bindslev-Jensen, C
  • Bedbrook, A
  • Bosnic-Anticevich, S
  • Brussino, L
  • Cardona, V
  • Cruz, AA
  • de Vries, G
  • Devillier, P
  • Fokkens, WJ
  • Fuentes-Pérez, JM
  • Gemicioglu, B
  • Haahtela, T
  • Huerta-Villalobos, YR
  • Ivancevich, JC
  • Kull, I
  • Kuna, P
  • Kvedariene, V
  • Linnemann, DEL
  • Laune, D
  • Makris, M
  • Melén, E
  • Morais-Almeida, M
  • Mösges, R
  • Mullol, J
  • O'Hehir, RE
  • Papadopoulos, NG
  • Prokopakis, EP
  • Psarros, F
  • Regateiro, FS
  • Reitsma, S
  • Samolinski, B
  • Scichilone, N
  • da Silva, J
  • Stellato, C
  • Todo-Bom, A
  • Tomazic, PV
  • Salmi, ST
  • Valero, A
  • Valiulis, A
  • Valovirta, E
  • van Eerd, M
  • Ventura, MT
  • Yorgancioglu, A
  • Basagaña, X
  • Antó, JM
  • Bousquet, J

Unidades de investigação

Abstract

Background MASK-air (R) is an app that supports allergic rhinitis patients in disease control. Users register daily allergy symptoms and their impact on activities using visual analog scales (VASs). We aimed to assess the concurrent validity, reliability, and responsiveness of these daily VASs. Methods Daily monitoring VAS data were assessed in MASK-air (R) users with allergic rhinitis. Concurrent validity was assessed by correlating daily VAS values with those of the EuroQol-5 Dimensions (EQ-5D) VAS, the Control of Allergic Rhinitis and Asthma Test (CARAT) score, and the Work Productivity and Activity Impairment Allergic Specific (WPAI-AS) Questionnaire (work and activity impairment scores). Intra-rater reliability was assessed in users providing multiple daily VASs within the same day. Test-retest reliability was tested in clinically stable users, as defined by the EQ-5D VAS, CARAT, or "VAS Work" (i.e., VAS assessing the impact of allergy on work). Responsiveness was determined in users with two consecutive measurements of EQ-5D-VAS or "VAS Work" indicating clinical change. Results A total of 17,780 MASK-air (R) users, with 317,176 VAS days, were assessed. Concurrent validity was moderate-high (Spearman correlation coefficient range: 0.437-0.716). Intra-rater reliability intraclass correlation coefficients (ICCs) ranged between 0.870 (VAS assessing global allergy symptoms) and 0.937 (VAS assessing allergy symptoms on sleep). Test-retest reliability ICCs ranged between 0.604 and 0.878-"VAS Work" and "VAS asthma" presented the highest ICCs. Moderate/large responsiveness effect sizes were observed-the sleep VAS was associated with lower responsiveness, while the global allergy symptoms VAS demonstrated higher responsiveness. Conclusion In MASK-air (R), daily monitoring VASs have high intra-rater reliability and moderate-high validity, reliability, and responsiveness, pointing to a reliable measure of symptom loads.

© 2021 The Authors. Clinical and Translational Allergy published by John Wiley and Sons Ltd on behalf of European Academy of Allergy and Clinical Immunology.

Dados da publicação

ISSN/ISSNe:
2045-7022, 2045-7022

Clinical and Translational Allergy  John Wiley & Sons Inc.

Tipo:
Review
Páginas:
-
Link para outro recurso:
www.scopus.com

Citações Recebidas na Web of Science: 27

Citações Recebidas na Scopus: 40

Documentos

  • Não há documentos

Métricas

Filiações mostrar / ocultar

Keywords

  • allergic rhinitis; mobile health; reliability; responsiveness; visual analog scales

Financiamento

Proyectos asociados

Prevalence and Characterisation of Asthma Patients According to Disease Severity in Portugal (EPI-ASTHMA) - NCT05169619

Investigador Principal: João de Almeida Lopes da Fonseca

Estudo Clínico Observacional (EPI-ASTHMA) . AstraZeneca . 2021

Utilização em estudos observacionais do Registo de Asma Grave Portugal.

Investigador Principal: João de Almeida Lopes da Fonseca

Estudo Observacional Académico (RAG) . 2020

Seroprevalence of SARS-CoV-2 and assessment of epidemiologic determinants in Portuguese municipal workers

Investigador Principal: Bernardo Manuel De Sousa Pinto

Estudo Clínico Académico (SARS-CoV-2) . 2021

Use of secondary data, health technology assessment methods and economic modelling applied to penicillin allergy

Investigador Principal: João de Almeida Lopes da Fonseca

Estudo Clínico Académico . 2020

Using different data sources for the identification of asthma patients and those at high risk of adverse outcomes

Investigador Principal: João de Almeida Lopes da Fonseca

Estudo Clínico Académico . 2020

Phenotypes of Chronic Diseases of the Airways: Towards Multidimensional Data -Driven Profiling

Investigador Principal: João de Almeida Lopes da Fonseca

Estudo Clínico Académico . 2020

Citar a publicação

Partilhar a publicação